Literature DB >> 26100016

p300 Regulates Liver Functions by Controlling p53 and C/EBP Family Proteins through Multiple Signaling Pathways.

Meghan Breaux1, Kyle Lewis1, Leila Valanejad2, Polina Iakova1, Fengju Chen1, Qianxing Mo1, Estela Medrano1, Lubov Timchenko3, Nikolai Timchenko4.   

Abstract

The histone acetyltransferase p300 has been implicated in the regulation of liver biology; however, molecular mechanisms of this regulation are not known. In this paper, we examined these mechanisms using transgenic mice expressing a dominant negative p300 molecule (dnp300). While dnp300 mice did not show abnormal growth within 1 year, these mice have many alterations in liver biology and liver functions. We found that the inhibition of p300 leads to the accumulation of heterochromatin foci in the liver of 2-month-old mice. Transcriptome sequencing (RNA-Seq) analysis showed that this inhibition of p300 also causes alterations of gene expression in many signaling pathways, including chromatin remodeling, apoptosis, DNA damage, translation, and activation of the cell cycle. Livers of dnp300 mice have a high rate of proliferation and a much higher rate of proliferation after partial hepatectomy. We found that livers of dnp300 mice are resistant to CCl4-mediated injury and have reduced apoptosis but have increased proliferation after injury. Underlying mechanisms of resistance to liver injury and increased proliferation in dnp300 mice include ubiquitin-proteasome-mediated degradation of C/EBPα and translational repression of the p53 protein by the CUGBP1-eukaryotic initiation factor 2 (eIF2) repressor complex. Our data demonstrate that p300 regulates a number of critical signaling pathways that control liver functions.
Copyright © 2015, American Society for Microbiology. All Rights Reserved.

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 26100016      PMCID: PMC4525310          DOI: 10.1128/MCB.00421-15

Source DB:  PubMed          Journal:  Mol Cell Biol        ISSN: 0270-7306            Impact factor:   4.272


  32 in total

1.  Aging reduces proliferative capacities of liver by switching pathways of C/EBPalpha growth arrest.

Authors:  Polina Iakova; Samir S Awad; Nikolai A Timchenko
Journal:  Cell       Date:  2003-05-16       Impact factor: 41.582

2.  Cooperation of C/EBP family proteins and chromatin remodeling proteins is essential for termination of liver regeneration.

Authors:  Jingling Jin; Il-Hwa Hong; Kyle Lewis; Polina Iakova; Meghan Breaux; Yanjun Jiang; Emily Sullivan; Nicole Jawanmardi; Lubov Timchenko; Nikolai A Timchenko
Journal:  Hepatology       Date:  2014-11-20       Impact factor: 17.425

3.  Elimination of C/EBPalpha through the ubiquitin-proteasome system promotes the development of liver cancer in mice.

Authors:  Guo-Li Wang; Xiurong Shi; Simon Haefliger; Jingling Jin; Angela Major; Polina Iakova; Milton Finegold; Nikolai A Timchenko
Journal:  J Clin Invest       Date:  2010-07       Impact factor: 14.808

4.  Epigenetic changes play critical role in age-associated dysfunctions of the liver.

Authors:  Jingling Jin; Guo-Li Wang; Polina Iakova; Xiurong Shi; Simon Haefliger; Milton Finegold; Nikolai A Timchenko
Journal:  Aging Cell       Date:  2010-10       Impact factor: 9.304

5.  Activation of basal gluconeogenesis by coactivator p300 maintains hepatic glycogen storage.

Authors:  Ling He; Jia Cao; Shumei Meng; Anlin Ma; Sally Radovick; Fredric E Wondisford
Journal:  Mol Endocrinol       Date:  2013-06-14

Review 6.  Mechanisms of p53 degradation.

Authors:  Chuck C-K Chao
Journal:  Clin Chim Acta       Date:  2014-08-27       Impact factor: 3.786

7.  Age-associated change of C/EBP family proteins causes severe liver injury and acceleration of liver proliferation after CCl4 treatments.

Authors:  Il-Hwa Hong; Kyle Lewis; Polina Iakova; Jingling Jin; Emily Sullivan; Nicole Jawanmardi; Lubov Timchenko; Nikolai Timchenko
Journal:  J Biol Chem       Date:  2013-11-22       Impact factor: 5.157

8.  The genetic regulation of the terminating phase of liver regeneration.

Authors:  Ingvild E Nygård; Kim E Mortensen; Jakob Hedegaard; Lene N Conley; Trine Kalstad; Christian Bendixen; Arthur Revhaug
Journal:  Comp Hepatol       Date:  2012-11-20

9.  Transcript assembly and quantification by RNA-Seq reveals unannotated transcripts and isoform switching during cell differentiation.

Authors:  Cole Trapnell; Brian A Williams; Geo Pertea; Ali Mortazavi; Gordon Kwan; Marijke J van Baren; Steven L Salzberg; Barbara J Wold; Lior Pachter
Journal:  Nat Biotechnol       Date:  2010-05-02       Impact factor: 54.908

10.  TopHat: discovering splice junctions with RNA-Seq.

Authors:  Cole Trapnell; Lior Pachter; Steven L Salzberg
Journal:  Bioinformatics       Date:  2009-03-16       Impact factor: 6.937

View more
  5 in total

1.  Downregulation of nuclear ING3 expression and translocalization to cytoplasm promotes tumorigenesis and progression in head and neck squamous cell carcinoma (HNSCC).

Authors:  Xiaohan Li; Qun Zhang; Mingming Zhang; Yusong Luo; Yaping Fu
Journal:  Histol Histopathol       Date:  2019-12-30       Impact factor: 2.303

2.  CUG-binding protein 1 regulates HSC activation and liver fibrogenesis.

Authors:  Xingxin Wu; Xudong Wu; Yuxiang Ma; Fenli Shao; Yang Tan; Tao Tan; Liyun Gu; Yang Zhou; Beicheng Sun; Yang Sun; Xuefeng Wu; Qiang Xu
Journal:  Nat Commun       Date:  2016-11-17       Impact factor: 14.919

3.  Protective Effects of Oridonin on Acute Liver Injury via Impeding Posttranslational Modifications of Interleukin-1 Receptor-Associated Kinase 4 (IRAK4) in the Toll-Like Receptor 4 (TLR4) Signaling Pathway.

Authors:  Min Shi; Yilin Deng; Heguo Yu; Ling Xu; Cuicui Shi; Jiong Chen; Guangming Li; Yiqi Du; Yu-Gang Wang
Journal:  Mediators Inflamm       Date:  2019-09-12       Impact factor: 4.711

4.  Endothelial p300 Promotes Portal Hypertension and Hepatic Fibrosis Through C-C Motif Chemokine Ligand 2-Mediated Angiocrine Signaling.

Authors:  Jinhang Gao; Bo Wei; Mengfei Liu; Petra Hirsova; Tejasav S Sehrawat; Sheng Cao; Xiao Hu; Fei Xue; Usman Yaqoob; Ningling Kang; Huarui Cui; William C K Pomerantz; Enis Kostallari; Vijay H Shah
Journal:  Hepatology       Date:  2021-04-19       Impact factor: 17.298

5.  Gankyrin Promotes Tumor-Suppressor Protein Degradation to Drive Hepatocyte Proliferation.

Authors:  Amber M D'Souza; Yanjun Jiang; Ashley Cast; Leila Valanejad; Mary Wright; Kyle Lewis; Meenasri Kumbaji; Sheeniza Shah; David Smithrud; Rebekah Karns; Soona Shin; Nikolai Timchenko
Journal:  Cell Mol Gastroenterol Hepatol       Date:  2018-05-24
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.